Prime Medicine, Inc. Shareholders Equity (Total)

Shareholders Equity (Total) of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Total) growth rates and interactive chart. Shareholder equity, also referred to as shareholders' equity and stockholders' equity, it a corporation's owners' residual claim after debts have been paid. Equity is equal to a firm's total assets minus its total liabilities. It is found on a company's balance sheet and it's the total equity available to common shareholders (after accounting for preferred equity). Also called book value or net book value.

Highlights and Quick Summary

  • Shareholders Equity (Total) for the quarter ending September 30, 2023 was $194 Million (a -19.22% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Total) decreased by -38.67%
  • Annual Shareholders Equity (Total) for 2022 was $316 Million (a 32.02% increase from previous year)
  • Annual Shareholders Equity (Total) for 2021 was $240 Million (a 615.66% increase from previous year)
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Total) of Prime Medicine, Inc.

Most recent Shareholders Equity (Total)of PRME including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Total) of Prime Medicine, Inc.

Prime Medicine, Inc. Shareholders Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $193.96 $240.1 $278.8 – –
2022 $316.27 $172.7 $0.0 $0.0 $316.27
2021 – – – $0.0 $239.56
2020 $0.0 – – – $33.47

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com